相关实验视频

Updated: Jan 12, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

通过皮肤电针点刺激可以预防术后的恶心和吐吗?

Yingying Liu¹, Zhen Chen², Zhiqiang Zhang²

¹The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, China; Department of Anesthesiology, Ningbo No.6 Hosipital, Ningbo, Zhejiang, China.

Complementary therapies in medicine

|November 6, 2025

概括

通过皮肤进行电针点刺激 (TEAS) 可以帮助预防术后恶心和吐 (PONV). 需要进一步的研究来优化TEAS参数,并标准化其用于PONV预防的临床应用.

科学领域:

麻醉学麻醉学
胃肠病学胃肠病学
神经学神经学

背景情况:

手术后恶心和吐 (PONV) 是一种常见的并发症,影响患者的康复和医疗费用.
PONV可能会导致严重的问题,如吸血,出血和长时间住院.

研究的目的:

审查PONV的风险因素.
探索TEAS可以防止PONV的机制.
讨论TEAS用于PONV预防的临床应用.

主要方法:

对PONV风险因素的文献综述.
讨论TEAS在PONV预防中的拟议机制 (例如,脑肠轴,自主神经功能).
对PONV中TEAS目前临床应用和研究需求的分析.

主要成果:

在降低PONV发病率方面,TEAS显示出有前途.
潜在的机制包括大脑-肠轴和自主神经系统的调制.
标准化应用需要进一步的机械和临床研究.

结论:

TEAS是术后PONV预防的可行策略.
优化参数和进行高质量的临床试验对于广泛采用至关重要.
进一步的研究将加强TEAS对PONV的标准化临床使用.

关键词:

针点电刺激的电刺激麻醉麻醉是一种麻醉.在手术后出现恶心.手术后出现吐和吐.通过皮肤进行针点电刺激.

更多相关视频

Laboratory Administration of Transcutaneous Auricular Vagus Nerve Stimulation taVNS: Technique, Targeting, and Considerations

Laboratory Administration of Transcutaneous Auricular Vagus Nerve Stimulation taVNS: Technique, Targeting, and Considerations

Published on: January 7, 2019

Acupoint Needle-Embedding Combined with Ironing Therapy for Postoperative Pain After Anal Surgery

Acupoint Needle-Embedding Combined with Ironing Therapy for Postoperative Pain After Anal Surgery

Published on: June 23, 2023

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...